Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

NCT00266344 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

NCT00103818 ·Status: COMPLETED ·Phase: PHASE3

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

NCT00266357 ·Status: TERMINATED ·Phase: PHASE2

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

NCT00420810 ·Status: TERMINATED ·Phase: PHASE3

A Study of Gaboxadol in Primary Insomnia

NCT00209846 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia

NCT00209937 ·Status: COMPLETED ·Phase: PHASE3

A Study of Gaboxadol in Primary Insomnia

NCT00209963 ·Status: COMPLETED ·Phase: PHASE3

A Study of Gaboxadol in Primary Insomnia

NCT00209924 ·Status: COMPLETED ·Phase: PHASE3

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

NCT00280436 ·Status: COMPLETED ·Phase: PHASE2

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

NCT00209950 ·Status: COMPLETED ·Phase: PHASE3

A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)

NCT01021813 ·Status: COMPLETED ·Phase: PHASE3

Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)

NCT00792298 ·Status: COMPLETED ·Phase: PHASE2

Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)

NCT01021852 ·Status: COMPLETED ·Phase: PHASE2

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

NCT00280423 ·Status: COMPLETED ·Phase: PHASE2

Effects of Insomnia on Simulated Driving (MK-0000-183-00)

NCT01209728 ·Status: COMPLETED ·Phase: PHASE1

A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia

NCT00748592 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

NCT02841709 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274

NCT02852395 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

NCT00569972 ·Status: COMPLETED ·Phase: PHASE2

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

NCT00551148 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)

NCT01097629 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity

NCT02464046 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)

NCT01097616 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

NCT00784875 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)

NCT02750306 ·Status: COMPLETED ·Phase: PHASE3